Search search Menu Home News Symbioze won the Pharmapack Award 2021 Symbioze won the Pharmapack Award 2021 12/10/2021 Symbioze, the smart, high volume and sustainable on-body injector platform developed by Nemera, wins the ‘Connected Devices and Wearables’ Award at Pharmapack 2021 On October 12th, during the Pharmapack Awards Ceremony, a team of industry experts awarded Symbioze, Nemera’s large-volume on-body injector, with the Pharmapack Award in the “Connected Devices and Wearables” category. Nemera’s novel on-body injector platform, Symbioze, comprises of a reusable main unit and disposable prefilled drug container module. It offers an ideal balance between the need to deliver advanced formulations at high volumes, up to 20 ml – and patient’s ease-of-use required for self-administration at home. It is the perfect combination between design robustness, ease of use, connectivity, and sustainability, for a seamless and enhanced injection experience. Symbioze is specifically tailored to administer complex drugs, such as biologic therapies, thanks to a highly engineered, reliable drug delivery system. It is suitable for large volumes such as 20ml and beyond, while preserving the formulation integrity – which is critical especially with monoclonal antibodies. It is designed to reconcile complex drugs injection with stakeholders’ (patients, HCP or payers) most demanding needs, with enough flexibility for adjustment to any pathology, targeted patient population and drug posology. Its reusable core technology can be re-used across multiple injections, leveraging its sustainable benefit for pharmaceutical players. “We are very delighted and pleased to receive this prestigious award. This is a recognition to our long-standing commitment to put patients first as well as our innovation capabilities.” – said Séverine Duband, Nemera’s Marketing Director, Drug Delivery Devices – “Over the last decade, several trends impacted the parenteral environement: shift towards at-home and value-based care, growth of biologics, connected health technologies, waste management. These continuously fueled a need for an easy self administration of large dose volumes. This is why, we developped our on-body injector platform Symbioze, to deliver large volumes at home, in a sustainable and user-friendly way.” Bernhard Rohn, VP of Strategy and Marketing, added: “We are very delighted to have received the Pharmapack award for our Symbioze wearable. We developed Symbioze to provide an intuitive and easy-to-use solution for patients, combining high injection volumes up to 20ml, a sustainable reusable/disposable product architecture and compatibility with standard pharmaceutical filling- and final-assembly processes.” Launched in 1997, the Pharmapack Awards celebrate the latest innovations from packaging companies within the drugs, medical devices, health products and veterinary drugs sectors. Symbioze at a glance: BENEFITS Sustainable and cost-effective Reusable electromechanical part with disposable drug-containing module Intuitive and easy to use for optimum treatment adherence Simultaneous removal of ergonomic needle safety cap and adhesive liner, minimizing steps-of-use Provides live injection monitoring, audio-visual feedback, and failure mode control Enhanced treatment management with a broad range of connectivity features: treatment information, historical trending, infusion status, compliance… Easy pairing between device manager application and the core system Ideal for complex, novel drugs administration whilst staying in line with pharma standards Enables large volume injection (up to 20ml), with adjustable parameters (i.e: flowrate, viscosities, dose volume…) Specifically tailored for biologics to preserve formulation integrity Compatible with standard cartridges, filling and manufacturing processes KEY FEATURES Patch-worn on-body injector Reusable: Consists of drug-containing disposable element and reusable, rechargeable onboard electronic modules Locking system for safe assembly and disassembly of reusable and disposable parts Ready to use: Prefilled and preloaded drug cartridge for patient’s safety Automatic soft canula insertion via needle safety system with hidden needle throughout the injection Innovative fluid path to maintain sterility from manufacturing to device use Platform approach: Provides customization flexibility for adjustments to any pathology, targeted patient population and drug posology Can accommodate various drug volumes especially for large-volume administration (20ml) Connected: Drug recognition and verification via NFC communication Bluetooth built-in communication offers connectivity option You can learn more about Symbioze at https://www.nemera.net/products/parenteral/wearables-symbioze/ To download the press release : HERE About Nemera As a world-leading drug delivery device solutions provider, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are a holistic partner and help our customers succeed in the sprint to market of their combination products. From early device strategy to state-of-the-art manufacturing, we’re committed to the highest quality standards. Agile and open-minded, we work with our customers as colleagues. Together, we go the extra mile to fulfill our mission. For more information, visit www.nemera.net Share this article: Facebook Twitter LinkedIn Latest News 2021 Ear, Nose, Throat Our news PR A new ENT device: UniSpray 27/10/2021 We are happy to announce the launch of Unispray, our unidose system primarily for systemic-acting drug administration. Continue Reading 2021 Inhalation Our news PR Nemera joins IPAC-RS as an Associate Member 20/10/2021 Nemera is excited to announce that it has become an Associate Member of the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) Continue Reading 2021 Press article Focus on injectables in the ‘Pharmaceutical Post’ 23/11/2021 Severine Duband, our Marketing Director was interviewed by the journalist of the 'Pharmaceutical Post', to talk about Symbioze and how we developed the product. The main challenge for manufacturers is... Continue Reading 2021 Our news PR Nemera to build state-of-the-art manufacturing facility in Poland to serve more customers and patients 16/11/2021 Based in Szczecin, this facility extends Nemera’s manufacturing capabilities and will bring more drug delivery device solutions to patients.Following the dynamic growth of the drug delivery devices market, as a... Continue Reading See All News Get in touch Get in touch to find out more about us, our solutions and what we can do for you. If you’re looking for job opportunities, please visit: Join Our Team First Name*: Last Name*: Company Name*: Job Title*: State: Country*: Please select... Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegowina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d'Ivoire Croatia (Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France France Metropolitan French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard and Mc Donald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao, People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macau Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia (Slovak Republic) Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands Spain Sri Lanka St. Helena St. Pierre and Miquelon Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (British) Virgin Islands (U.S.) Wallis and Futuna Islands Western Sahara Yemen Yugoslavia Zambia Zimbabwe Email*: Phone: Main Interest*: Please select... Our Services Our Products Other Channel (how did you hear about us?)*: Please select... Search Engine Social Media Website Exhibitions Press Word of Mouth Third party network Other Message*: Your personal data is intended for Nemera and its subsidiaries to process your request for information. You have rights over your personal data, such as the right to access, erase and object. For more information, see our Privacy Policy. * Required fields. LinkedIn Twitter Youtube Who We Are Privacy Policy Cookies policy Legal Policy 20 Avenue de la Gare 38290 La Verpillière - France T. +33 4 74 94 06 54 © 2021 Nemera. Website developed by Illustrate Digital